The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effects of testosterone deficiency or manipulation on prostate cancer.
Aksam Yassin
Honoraria - Bayer; Ferring
Research Funding - Bayer
Other Remuneration - Teva
Dany-Jan Yassin
No relevant relationships to disclose
Peter Hammerer
No relevant relationships to disclose